Vitro Biopharma Signs Multi-Million Dollar Operating Service Contract with European Wellness Biomedical Group

August 20, 2021

Vitro Biopharma Signs Multi-Million Dollar Operating Service Contract with European Wellness Biomedical Group

Golden, Colorado-August 19, 2021-Vitro Biopharma, Inc. announced the signing of a contract with European Wellness Biomedical Group headquartered in Kuala Lumpur, Malaysia and it’s start-up subsidiary BioPep being registered in Delaware, USA to develop FDA-approval of biological products derived from existing mitochondrial peptide extracts now used globally as treatment of various conditions including aesthetic dermatology and skin revitalization, autism spectrum disorders, cardiovascular, metabolic and degenerative disorders, CKD and fertility through its global network of 12 (twelve) biomedical regenerative centers located throughout Europe and Asia Pacific. The contract provides for direct payments to Vitro Biopharma, Inc. of $2 million over 2-years for its services to gain FDA approval.  The contract specifies distinct stages to gain FDA-approval including the steps needed to produce a research product for extensive preclinical and clinical testing to support an FDA IND filing, biomanufacturing infrastructure to support BLA-compliant upstream and downstream operations, development of a certified Quality Management System to support FDA-approval of target products and technology transfer to BioPep.

Click here to continue reading.




Also in News

Fitore and Infinivive logo
Vitro Biopharma Acquires Fitore Nutrition and Infinivive MD, Adding Revenues from Innovative Stem Cell Activation Products and Topical Cosmetic Stem Cell Serums

August 31, 2021 0 Comments

Golden, Colorado-August 31, 2021- Vitro Biopharma, Inc. ("Vitro') announced the acquisition of Fitore Nutrition ("Fitore") and Infinivive MD ("Infinivive"). Fitore, a private company headquartered in Denver, Colorado creates clinically validated supplements and sells them direct to consumers (D2C) via their unique digital marketing platform and SEO expertise.

Infinivive, located in Cherry Creek, Colorado developed the world's first topical cosmetic stem cell serum and is a nationally recognized company led by one of the top industry pioneers in the area of cosmetic surgery, Dr. Jack Zamora M.D.

Read More

Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells® to Treat COVID-19
Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells® to Treat COVID-19

August 20, 2021 0 Comments

Vitro Biopharma, Inc. announced receipt of FDA authorization and clearance to enroll patients in its phase I-IIa, randomized, double-blinded, placebo controlled study of the safety and efficacy of therapeutic treatment with AlloRx Stem Cells® in adults with COVID-19.  Our Investigational New Drug (IND) application  will investigate the clinical effects of AlloRx Stem Cells® by studying safety and efficacy in patients with moderate to severe COVID-19. 

Read More

Regulatory affairs
Vitro Biopharma Retains Leading Health Care Executive as Acting Director of Regulatory Affairs & Director

August 20, 2021 0 Comments

Vitro Biopharma, Inc. (formerly Vitro Diagnostics, Inc.)  announced the appointment of Dr. Caroline Mosessian, PhD, DRSc, FACMPE, ACHE as its  acting Director of Regulatory Affairs. Dr. Mosessian has an extensive background in regulatory  science including a PhD, MS and Masters in Healthcare Administration degrees from USC in  LA.

Read More